1. Tang M, Zhong M, Shang Y, Lin H, Deng J, Jiang H, Lu H, Zhang Y, Zhang W. Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway. Cell Mol Life Sci. 2008 Sep;65(18):2924-32. （IF=6.721）
2. Gong HP, Wang ZH, Jiang H, Fang NN, Li JS, Shang YY, Zhang Y, Zhong M, Zhang W. TRIB3 functional Q84R polymorphism is a risk factor for metabolic syndrome and carotid atherosclerosis. Diabetes Care. 2009 Jul;32(7):1311-3. （共同通讯，IF= 13.397）
3. Ti Y, Xie GL, Wang ZH, Bi XL, Ding WY, Wang J, Jiang GH, Bu PL, Zhang Y, Zhong M, Zhang W. TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model. Diabetes. 2011; 60(11):2963-74. （共同通讯，IF=7.273）
4. Wang ZH, Shang YY, Zhang S, Zhong M, Wang XP, Deng JT, Pan J, Zhang Y, Zhang W. Silence of TRIB3 Suppresses Atherosclerosis and Stabilizes Plaques in Diabetic ApoE-/-/LDLR-/- Mice. Diabetes. 2012 Feb;61(2):463-73. （IF=7.273）
5. Li Y, Ding W, Wang H, Song N, Lin L, Wang Z, Zhong M, Zhang Y, Zhang W. Relationship of CHA2DS2-VASc and CHADS2 Score to Left Atrial Remodeling Detected by Velocity Vector Imaging in Patients with Atrial Fibrillation. PLoS One. 2013;8(10):e77653
6. Ding WY, Liu L, Wang ZH, Tang MX, Ti Y, Han L, Zhang L, Zhang Y, Zhong M, Zhang W. FP-receptor gene silencing ameliorates myocardial fibrosis and protects from diabetic cardiomyopathy. J Mol Med. 2014;92(6):629-40.
7. Ding WY, Li WB, Ti Y, Bi XP, Sun H, Wang ZH, Zhang Y, Zhang W, Zhong M. Protection from renal fibrosis, putative role of TRIB3 gene silencing. Exp Mol Pathol. 2014;96(1):80-4.
8. Wang J, Han L, Wang ZH, Ding WY, Shang YY, Tang MX, Li WB, Zhang Y, Zhang W, Zhong M. Overexpression of STAMP2 suppresses atherosclerosis and stabilizes plaques in diabetic mice. J Cell Mol Med. 2014;18(4):735-48.
9. Fu KL, Fan GQ, Han L, Wang XZ, Wang J, Wang YS, Zhong M, Zhang Y, Zhang W, Wang ZH. Impact of type 2 diabetes mellitus on hospitalization costs in older patients with acute myocardial infarction. Clin Interv Aging. 2014;9:711-8.
10. Fan GQ, Fu KL, Jin CW, Wang XZ, Han L, Wang H, Zhong M, Zhang Y, Zhang W, Wang ZH. A medical costs study of older patients with acute myocardial infarction and metabolic syndrome in hospital. Clin Interv Aging. 2015;10:329-37.
11. Peng J, Zhao Y, Zhang H, Liu Z, Wang Z, Tang M, Zhong M, Lu F, Zhang W. Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. Hypertens Res. 2015;38(2):123-31.
12. Zhang L, Ding WY, Wang ZH, Tang MX, Wang F, Li Y, Zhong M, Zhang Y, Zhang W. Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. J Transl Med. 2016;14(1):109.
13. Wang F, Han L, Qin RR, Zhang YY, Wang D, Wang ZH, Tang MX, Zhang Y, Zhong M, Zhang W. Overexpressing STAMP2 attenuates adipose tissue angiogenesis and insulin resistance in diabetic ApoE-/-/LDLR-/- mouse via a PPARγ/CD36 pathway. J Cell Mol Med. 2017;21(12):3298-308.
14. Li Y, Yan H, Wang F, Huang S, Zhang Y, Wang Z, Zhong M, Zhang W. Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice. Biochem Biophys Res Commun. 2017;486(3):693-9.
